The Latest Breaking News from Pfizer

Trump’s approach to lowering drug costs is raising questions - Roll Call

Several drug pricing experts say without key details, it’s hard to call the individual pharma deals a win for the Trump administration.

Roll Call · Oct 22, 2025

COVID-19 vaccines may help some cancer patients fight tumors

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors

The Independent UK · Oct 22, 2025

Steve Cohen's Point72 Buys $20M of Surging Biotech Stock That Recently Priced $125M Offering to Advance Myeloma Treatment

Cohen's Point72 purchased over 8 million shares of C4 Therapeutics within weeks of the company announcing phase 1 trial data of a drug to treat myeloma and raised $125 million to fund upcoming trials.

International Business Times UK · Oct 21, 2025

Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs?

President Donald Trump just dropped a political bomb into one of Wall Street's hottest trades. His promise to cut the cost of Novo Nordisk A/S (NYSE:NVO) blockbuster drug Ozempic from around $1,300 to $150 isn't just about affordability—it's about shaking the foundations of the GLP-1 gold rush that's reshaped healthcare…

Benzinga · Oct 17, 2025

5 Things Retirees Need To Know About the New Trump Drug Program

Will TrumpRx help cut prescription costs for uninsured retirees? Learn how this new drug program could impact retirees' prescription budgets come 2026.

GOBankingRates · Oct 16, 2025

Pfizer’s Q3 2025 Earnings: What to Expect

Pfizer is expected to report its third-quarter results next month, and analysts are projecting a double-digit decline in its earnings.

Barchart · Oct 16, 2025

Pfizer Seeks Expanded Use Approval For Breast Cancer Drug

Pfizer Inc. (NYSE:PFE) on Tuesday announced the initial results from a clinical trial called HER2CLIMB-05.  

Benzinga · Oct 14, 2025

Trump Secures Major Win as AstraZeneca Joins Pfizer in Lowering US Drug Prices

AstraZeneca joins Pfizer in cutting US drug prices under Trump's new deal to offer lower costs for Medicaid patients.

International Business Times · Oct 13, 2025

AstraZeneca Joins Trump's Push to Make Medicines Cheaper — But Why Are Critics Skeptical?

US President Donald Trump announced a deal with UK pharmaceutical AstraZeneca to lower certain drugs for government's Medicaid health plan.

International Business Times UK · Oct 12, 2025

AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs

Company will sell some medicines at a discount to government’s Medicaid health plan in exchange for tariff relief

The Guardian - US · Oct 10, 2025